Dengue virus envelope glycoprotein structure: New insight into its interactions during viral entry
about
A small-molecule dengue virus entry inhibitorPeptide inhibitors of dengue virus and West Nile virus infectivityPrinciples of virus structural organizationAttenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface.Insight into a conserved lifestyle: protein-carbohydrate adhesion strategies of vector-borne pathogens.Development of a humanized monoclonal antibody with therapeutic potential against West Nile virusType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesA dengue receptor as possible genetic marker of vector competence in Aedes aegyptiSecretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive LipoproteinsClosing the door on flaviviruses: Entry as a target for antiviral drug designProgress on the development of therapeutics against West Nile virusAntibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different GenotypesPCP Consensus Sequences of Flaviviruses: Correlating Variance with Vector Competence and Disease PhenotypeSulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical applicationDengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arbovirusesHuman Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in VivoA molecularly cloned, live-attenuated japanese encephalitis vaccine SA14-14-2 virus: a conserved single amino acid in the ij Hairpin of the Viral E glycoprotein determines neurovirulence in miceStructural differences observed in arboviruses of the alphavirus and flavivirus genera.Complex modulation of the Aedes aegypti transcriptome in response to dengue virus infection.An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeysDengue virus specific dual HLA binding T cell epitopes induce CD8+ T cell responses in seropositive individuals.Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity.Development of effective therapies against West Nile virus infection.Lineage shift in Indian strains of Dengue virus serotype-3 (Genotype III), evidenced by detection of lineage IV strains in clinical cases from Kerala.The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Therapeutic antibodies as a treatment option for dengue fever.Peptide inhibitors against dengue virus infection.Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.Genomics, proteomics and evolution of dengue virus.Detection and sequencing of defective viral genomes in C6/36 cells persistently infected with dengue virus 2.Dengue-2-virus-interacting polypeptides involved in mosquito cell infection.Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations.Receptor-Guided De Novo Design of Dengue Envelope Protein Inhibitors.Identification of sequence motifs involved in Dengue virus-host interactions.Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2.Chloroquine interferes with dengue-2 virus replication in U937 cells.Facile synthesis of tetrasaccharide aided by fluorous chemistry toward a dengue virus vaccine.Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells.
P2860
Q22309806-956130D4-6C1E-403C-9743-400D4558D55FQ24813811-A1A79710-F131-44AD-914B-3FFEFF412A14Q27021684-B1B732B0-47B3-480B-9837-469754B4EA90Q27469842-B8668600-2F74-4A4C-BD27-3D38AD11FC0BQ27472742-1CA30584-2F73-4A9B-9EC0-8D7DBC5B30AAQ27473186-1EA82F51-46CE-4154-8B25-C1A40F22B843Q27485031-7C227FB1-F4F0-4A49-BBFA-6C67A7CCFF65Q27486539-52B475CC-7E83-4F6C-B04C-8D62DF42F91AQ27487558-62F5FC65-714B-40DD-A8D1-A17786C6B4A7Q27487953-DF938DBB-75F0-4F8D-A703-A6B3AAB98FDDQ27489893-8BFF5228-64F0-4D60-8A63-6EA606252C71Q27490452-F541206C-A410-417D-8BB3-E867D702B9BDQ27490925-8B831E71-F3F0-46C6-95B2-21CBC26F3E03Q28486916-E8DCC073-D742-46F3-AB1C-88C79F96BDC3Q28577861-D7565003-65C0-4E0F-9E5B-8046B1C6A435Q33588683-B3E85EC7-E97C-4704-828A-414D868964E2Q33982616-23831B3A-E1C8-44C2-8373-C82611A26C21Q34275645-6E0C8B83-AB0C-4B8E-B8DE-B0750E41CAE6Q34500405-4A5B96EC-6CF7-483E-810F-E5D2F7D70443Q34552933-5615185B-7DE4-4F72-9DCF-2FEAD3FE9441Q35324935-E50FE6AD-7131-4BA9-B834-17B90FD087F8Q35886539-05C3E190-EE97-467F-9090-446065FBAA7CQ36172100-98C27F25-08A9-4CF0-B6A0-1A62A7421F0AQ36322125-69192AB9-A0BB-4D44-B7E4-31C046841607Q36687997-71C62F32-D433-4027-909E-EB8930F7C7E0Q37448171-A18968B6-5F69-46EE-9420-8952E8C8B89FQ37767654-D097FB97-8351-4295-B6C5-C41DD495B122Q38149195-511BF86C-C763-4035-BA2D-554525858CF7Q39017020-1E8A3274-D914-4A4E-BCF8-9100B17A0A10Q39039111-98FF5FDD-719E-47FD-982F-73961D839D14Q39078484-75A660CC-99A1-4F3D-8C98-96E426BB7BECQ39249018-230EE9DB-EA51-46BF-A993-1942C05C0B2AQ39689235-95F1CE77-1824-48B9-AA3B-8F774B450096Q40066916-E9AA59D1-1E6C-4897-9B18-8076B1835F23Q40142168-9B54E6C6-3D9E-4F2C-8D1F-2B38699513D2Q40159006-3C036924-B18E-4D4F-ABCE-5267D243147BQ40189989-D8126C69-588A-4163-AE0A-C24622F7D57EQ40208955-9EF20CB0-08FA-471E-A03D-08A986724C5FQ40246936-AB5B4976-17BA-40A3-9776-0158A5FB4407Q40505862-5472C18F-EE70-45F0-A2B5-E580BD372E8E
P2860
Dengue virus envelope glycoprotein structure: New insight into its interactions during viral entry
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Dengue virus envelope glycopro ...... nteractions during viral entry
@ast
Dengue virus envelope glycopro ...... nteractions during viral entry
@en
Dengue virus envelope glycopro ...... nteractions during viral entry
@nl
type
label
Dengue virus envelope glycopro ...... nteractions during viral entry
@ast
Dengue virus envelope glycopro ...... nteractions during viral entry
@en
Dengue virus envelope glycopro ...... nteractions during viral entry
@nl
prefLabel
Dengue virus envelope glycopro ...... nteractions during viral entry
@ast
Dengue virus envelope glycopro ...... nteractions during viral entry
@en
Dengue virus envelope glycopro ...... nteractions during viral entry
@nl
P2860
P356
P1476
Dengue virus envelope glycopro ...... nteractions during viral entry
@en
P2860
P304
P356
10.1073/PNAS.1332695100
P407
P50
P577
2003-06-10T00:00:00Z